Showing results (211-220 of 246) with videos related to
Sort By:
Pageof 25
Thrombosis and Haemostasis|March 11, 2008
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situationsAndreas Tiede, R Campbell Tait, Don W Shaffer, et al.The Lancet. Haematology|September 19, 2025
Sustainable anticoagulation for climate resilient careBingwen Eugene Fan, Kevin Milla, Scott McAlister, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2024
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 yearsNeil A Goldenberg, Sam Schulman, John M Kittelson, et al.Journal of Thrombosis and Haemostasis : JTH|March 12, 2023
Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysisMatteo Candeloro, Emanuele Valeriani, Manuel Monreal, et al.BMJ Open|May 1, 2024
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trialAnne Holbrook, Sue Troyan, Victoria Telford, et al.European Heart Journal|July 13, 2023
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and HaemostasisBruna Gigante, Jerrold H Levy, Eric van Gorp, et al.Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.JAMA|January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical TrialNeil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.Journal of Thrombosis and Haemostasis : JTH|March 19, 2024
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Donald M Arnold, Charlotte A Bradbury, et al.Pageof 25